News summary · News
CareTrust REIT (NYSE:CTRE) Stock Price Target Lowered at UBS Group
UBS lowered its CareTrust REIT price target from US$48 to US$44 while keeping a Buy rating, according to MarketBeat's October 13 report citing Benzinga. Against the US$36.54 trading price used in the article, the revised target implied approximately 20.4% potential appreciation. That comparison reflects the brokerage's forecast, with no assurance of achieving it.
The same report describes a broader Moderate Buy consensus and US$43.92 average analyst target. CareTrust's portfolio centers on healthcare facilities operated by third parties; its long-term leases include arrangements assigning property taxes, insurance and maintenance to tenants.
Research considerations
REIT news can cover acquisitions, operating results, distributions, capital raising, and liquidity. Publicly traded and nontraded structures can have different reporting and liquidity arrangements. Identify the actual vehicle before comparing an announcement with other investments.
- Which REIT or portfolio is covered, and what period does the announcement describe?
- How do the reported figures relate to debt, operating performance, distribution coverage, and liquidity?
This Sequoia Research summary was prepared with AI assistance from the credited source. It is not independent verification of the source’s claims. The original publisher retains authorship of its reporting; follow the source link for the complete article.
Explore Sequoia Research reports
News can help identify a development worth following. Our investment-offering reports provide a separate, more detailed review of the properties, sponsors, financial assumptions, and risks behind the investment.
- Exclusive opinions & data points: Access our detailed findings, key data points, and independent perspective on the offering’s strengths and risks.
- Thorough expert analysis: Explore a detailed review of the property, sponsor, financial projections, fees, and business plan by industry experts.
- Comparison scorecard: Compare key factors across reviewed offerings using a consistent scorecard that brings our analysis together.
Visit the investment research library to see available offerings and report details. Coverage of a news item does not mean Sequoia Research has reviewed or offers a report on the investment mentioned.